quinuclidines has been researched along with Sensitivity and Specificity in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jangid, AG; Mistri, HN; Pudage, A; Rathod, DM; Shrivastav, PS | 1 |
| Klíma, J; Macek, J; Ptáček, P | 1 |
| Gu, Y; Lu, Z; Ou, N; Wang, Y; Zhang, P | 1 |
| Hosokawa, R; Iida, T; Inagaki, T; Inenaga, K; Ono, K; Wakasugi-Sato, N | 1 |
| Lehmann, BD; Pietenpol, JA | 1 |
| Ali, D; Andersson, PO; Andrén, O; Bykov, VJ; Cherif, H; Juliusson, G; Lehmann, S; Moshfegh, A; Paul, C; Tidefelt, U; Uggla, B; Wiman, KG; Yachnin, J | 1 |
| Barták, P; Bednár, P; Hlavác, J; Lemr, K; Sevcík, J; Stránský, Z; Stýskala, J; Wiedermannová, I | 1 |
| Bradesi, S; Ennes, HS; Kokkotou, E; Marvizon, JC; Mayer, EA; McLean, P; McRoberts, JA; Mittal, Y; Ohning, G; Patierno, S; Pothoulakis, C; Simeonidis, S; Sternini, C | 1 |
| Liu, K; Qiao, J; Ruan, J; Xu, Y; Xue, M; Yuan, S; Zhang, Z | 1 |
| Colli, E; Digesu, GA; Olivieri, L | 1 |
| Aoki, T; Iwatsubo, T; Kamimura, H; Soeishi, Y; Yanagihara, T | 1 |
| Brown, GR; Davidson, RG; Freeman, S; Holdgate, GA; Mallion, KB; McTaggart, F; Mirrlees, DJ; Smith, GJ; Ward, WH | 1 |
| Brown, GR; Davidson, RG; Eakin, MA; Freeman, S; Girdwood, PA; Holdgate, GA; Mallion, KB; McTaggart, F; Ward, WH | 1 |
| Nickerson, B | 1 |
| Hayakawa, T; Hoshino, N; Minouchi, T; Shibata, N; Takada, K; Yamaji, A | 1 |
| Boulay, SF; Cohen, VI; Danesh, RA; McPherson, DW; Rayeq, MR; Reba, RC; Sood, VK; Zeeberg, BR | 1 |
2 review(s) available for quinuclidines and Sensitivity and Specificity
| Article | Year |
|---|---|
Targeting mutant p53 in human tumors.
Topics: Antineoplastic Agents; Disease-Free Survival; Female; Humans; Male; Molecular Targeted Therapy; Mutation; Neoplasms; Patient Safety; Quinuclidines; Risk Assessment; Sensitivity and Specificity; Signal Transduction; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53 | 2012 |
Overactive bladder treatments in early phase clinical trials.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Drugs, Investigational; Guanidines; Humans; Mice; Muscarinic Antagonists; Quinuclidines; Receptors, Muscarinic; Sensitivity and Specificity; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2007 |
14 other study(ies) available for quinuclidines and Sensitivity and Specificity
| Article | Year |
|---|---|
Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective alpha1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma.
Topics: Adrenergic alpha-Antagonists; Chromatography, Liquid; Drug Stability; Humans; Male; Methyl Ethers; Muscarinic Antagonists; Propranolol; Quinazolines; Quinuclidines; Reference Standards; Sensitivity and Specificity; Solifenacin Succinate; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrahydroisoquinolines | 2008 |
Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Adult; Chromatography, High Pressure Liquid; Drug Stability; Humans; Linear Models; Male; Middle Aged; Quinuclidines; Reproducibility of Results; Sensitivity and Specificity; Solifenacin Succinate; Tandem Mass Spectrometry; Tetrahydroisoquinolines | 2010 |
Determination of palonosetron in human urine by LC-MS/MS.
Topics: Chromatography, Liquid; Humans; Isoquinolines; Palonosetron; Quinuclidines; Sensitivity and Specificity; Tandem Mass Spectrometry | 2011 |
Distinct effects of cevimeline and pilocarpine on salivary mechanisms, cardiovascular response and thirst sensation in rats.
Topics: Analysis of Variance; Animals; Cardiovascular System; Drinking; Muscarinic Agonists; Parotid Gland; Pilocarpine; Quinuclidines; Rats; Rats, Wistar; Salivation; Sensitivity and Specificity; Subfornical Organ; Thiophenes; Thirst | 2012 |
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genes, p53; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Molecular Targeted Therapy; Patient Safety; Pharmacogenetics; Prospective Studies; Prostatic Neoplasms; Quinuclidines; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2012 |
Capillary electrophoresis/mass spectrometry: a promising tool for the control of some physiologically hazardous compounds. I-derivatives of 3-quinuclidinol.
Topics: Electrophoresis, Capillary; Fresh Water; Hallucinogens; Mass Spectrometry; Molecular Structure; Quinuclidines; Quinuclidinyl Benzilate; Sensitivity and Specificity; Water Pollutants | 2002 |
The role of neurokinin 1 receptors in the maintenance of visceral hyperalgesia induced by repeated stress in rats.
Topics: Animals; Base Sequence; Blotting, Western; Disease Models, Animal; Electrodes, Implanted; Electromyography; Gastrointestinal Motility; Gene Expression Regulation; Hyperalgesia; Male; Molecular Sequence Data; Piperidines; Quinuclidines; Rats; Rats, Wistar; Receptors, Neurokinin-1; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Stress, Physiological | 2006 |
Determination of penehyclidine by gas chromatographic-mass spectrometry and its application to pharmacokinetics in humans, rabbits and mice.
Topics: Adult; Animals; Drug Stability; Gas Chromatography-Mass Spectrometry; Humans; Male; Mice; Quinuclidines; Rabbits; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Male; Microchemistry; Quinuclidines; Rats; Rats, Inbred F344; Sensitivity and Specificity; Solifenacin Succinate; Tetrahydroisoquinolines | 2007 |
Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.
Topics: Animals; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Female; Kinetics; Liver; Mevalonic Acid; Quinuclidines; Rats; Rats, Inbred Strains; Sensitivity and Specificity; Tritium | 1996 |
Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine.
Topics: Animals; Binding Sites; Callithrix; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Kinetics; Microsomes, Liver; Quinuclidines; Rats; Sensitivity and Specificity | 1996 |
The determination of a degradation product in clidinium bromide drug substance by capillary electrophoresis with indirect UV detection.
Topics: Drug Stability; Electrophoresis, Capillary; Parasympatholytics; Quinuclidines; Quinuclidinyl Benzilate; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1997 |
Simultaneous determination of glucocorticoids in plasma or urine by high-performance liquid chromatography with precolumn fluorimetric derivatization by 9-anthroyl nitrile.
Topics: Adult; Anthracenes; Child; Chromatography, High Pressure Liquid; Circadian Rhythm; Cortisone; Fluorescent Dyes; Glucocorticoids; Humans; Hydrocortisone; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisolone; Prednisone; Quinuclidines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Temperature; Time Factors | 1998 |
In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
Topics: Alzheimer Disease; Animals; Autoradiography; Binding, Competitive; Brain; Bromine Radioisotopes; Cryoultramicrotomy; Glycolates; Male; Quinuclidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptors, Muscarinic; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |